摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[(4S)-2-ethyl-5-oxo-1,3-dioxolan-4-yl]acetic acid | 1170702-13-2

中文名称
——
中文别名
——
英文名称
2-[(4S)-2-ethyl-5-oxo-1,3-dioxolan-4-yl]acetic acid
英文别名
(4S)-2-Ethyl-5-oxo-1,3-dioxolane-4-acetic acid
2-[(4S)-2-ethyl-5-oxo-1,3-dioxolan-4-yl]acetic acid化学式
CAS
1170702-13-2
化学式
C7H10O5
mdl
——
分子量
174.153
InChiKey
VBWHZEYYJTZAMI-VKZKZBKNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    72.8
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-[(4S)-2-ethyl-5-oxo-1,3-dioxolan-4-yl]acetic acid硼烷四氢呋喃络合物 作用下, 以 四氢呋喃 为溶剂, 反应 3.0h, 生成 cis-2-[(4S)-2-ethyl-5-oxo-1,3-dioxolan-4-yl]ethanol 、 trans-2-[(4S)-2-ethyl-5-oxo-1,3-dioxolan-4-yl]ethanol
    参考文献:
    名称:
    (+)-Brasilenyne 的全合成。分子内硅辅助交叉偶联反应的应用
    摘要:
    (+)-brasilenyne (1) 的第一个对映选择性全合成已在 19 个线性步骤中实现,1-(S)-苹果酸的总产率为 5.1%。包含 1,3-cis,cis 二烯单元的 oxonin 核心的构建是通过串联闭环复分解/硅辅助分子内交叉偶联反应完成的。此外,一个关键的炔丙基立体中心是通过由 TiCl(4) 促进的 1,3-二氧戊环的新型、高度非对映选择性环开口创建的。该反应通过氧代碳正离子中间体进行,不对称诱导完全由 l-苹果酸残基控制。C(8) 立体中心由试剂控制的不对称烯丙基硼化设置。
    DOI:
    10.1021/ja0466863
  • 作为产物:
    描述:
    L-苹果酸丙醛三氟化硼乙醚 作用下, 以 乙醚 为溶剂, 反应 3.5h, 以78.1%的产率得到2-[(4S)-2-ethyl-5-oxo-1,3-dioxolan-4-yl]acetic acid
    参考文献:
    名称:
    EP2230239
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • A METHOD FOR PREPARING 4-Ý9-(6-AMINOPURINE)¨-2-(S)-HYDROXYL-BUTYRIC ACID METHYL ESTER
    申请人:SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    公开号:EP2230239A1
    公开(公告)日:2010-09-22
    The present invention discloses a novel method for preparing and purifying 4-(6-Amino-purin-9-yl)-2(S)-hydroxy-butyric acid methyl ester. The preparation started from cheap and easily available L-malic acid, which was transformed to intermediate I after simultaneous protection of the groups of 1-carboxyl and 2-hydroxyl. The intermediate I was selectively reduced to intermediate alcohol II, whose hydroxyl group was further transformed to an easily leaving group to afford intermediate III. The intermediate III was nucleophilically substituted with adenine to afford intermediate IV The intermediate IV was deprotected and methyl-esterified simultaneously in methanol in the presence of an acid or a base to afford crude 4-(6-Amino-purin-9-yl)-2(S)-hydroxy-butyric acid methyl ester, which was purified by recrystallization to afford the purified product. Comparing with the prior preparation methods, the present method has advantages in low cost, mild conditions, high retention of the chiral center during the reaction, high productivity, great improvement in the quality and yield of the product and great decrease in cost, and thus is suitable for the production on a large scale.
    本发明公开了一种制备和纯化 4-(6-氨基-嘌呤-9-基)-2(S)-羟基丁酸甲酯的新方法。该制备方法从廉价易得的 L-苹果酸开始,在同时保护 1-羧基和 2-羟基后将其转化为中间体 I。中间体 I 被选择性地还原成中间体醇 II,其羟基进一步转化为易离去基团,得到中间体 III。中间体 IV 在甲醇中,在酸或碱的存在下同时进行脱保护和甲基酯化,得到粗制的 4-(6-氨基-嘌呤-9-基)-2(S)-羟基丁酸甲酯。与之前的制备方法相比,本方法具有成本低、条件温和、反应过程中手性中心保留率高、生产率高、产品质量和收率大大提高、成本大大降低等优点,适合大规模生产。
  • Method for Preparing 4-[9-(6-Aminopurine)]-2-(S)-Hydroxyl-Butyric Acid Methyl Ester
    申请人:Nan Fajun
    公开号:US20110201810A1
    公开(公告)日:2011-08-18
    The present invention discloses a novel method for preparing and purifying 4-(6-Amino-purin-9-yl)-2(S)-hydroxy-butyric acid methyl ester. The preparation started from cheap and easily available L-malic acid, which was transformed to intermediate I after simultaneous protection of the groups of 1-carboxyl and 2-hydroxyl. The intermediate I was selectively reduced to intermediate alcohol II, whose hydroxyl group was further transformed to an easily leaving group to afford intermediate III. The intermediate III was nucleophilically substituted with adenine to afford intermediate IV. The intermediate IV was deprotected and methyl-esterified simultaneously in methanol in the presence of an acid or a base to afford crude 4-(6-Amino-purin-9-yl)-2(S)-hydroxy-butyric acid methyl ester, which was purified by recrystallization to afford the purified product. Comparing with the prior preparation methods, the present method has advantages in low cost, mild conditions, high retention of the chiral center during the reaction, high productivity, great improvement in the quality and yield of the product and great decrease in cost, and thus is suitable for the production on a large scale.
  • US8247549B2
    申请人:——
    公开号:US8247549B2
    公开(公告)日:2012-08-21
  • EP2230239
    申请人:——
    公开号:——
    公开(公告)日:——
  • Total Synthesis of (+)-Brasilenyne. Application of an Intramolecular Silicon-Assisted Cross-Coupling Reaction
    作者:Scott E. Denmark、Shyh-Ming Yang
    DOI:10.1021/ja0466863
    日期:2004.10.1
    3-cis,cis diene unit was accomplished with a tandem ring-closing metathesis/silicon-assisted intramolecular cross-coupling reaction. In addition, a key propargylic stereogenic center was created through a novel, highly diastereoselective ring opening of a 1,3-dioxolanone promoted by TiCl(4). This reaction proceeded through an oxocarbenium ion intermediate and the asymmetric induction was fully controlled
    (+)-brasilenyne (1) 的第一个对映选择性全合成已在 19 个线性步骤中实现,1-(S)-苹果酸的总产率为 5.1%。包含 1,3-cis,cis 二烯单元的 oxonin 核心的构建是通过串联闭环复分解/硅辅助分子内交叉偶联反应完成的。此外,一个关键的炔丙基立体中心是通过由 TiCl(4) 促进的 1,3-二氧戊环的新型、高度非对映选择性环开口创建的。该反应通过氧代碳正离子中间体进行,不对称诱导完全由 l-苹果酸残基控制。C(8) 立体中心由试剂控制的不对称烯丙基硼化设置。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物